My watch list
my.bionity.com  
Login  

Influenza

News Influenza

  • Tactics of new Middle East virus suggest treating by altering lung cells' response to infection

    A new virus that causes severe breathing distress and kidney failure elicits a distinctive airway cell response to allow it to multiply. Scientists studying the Human Coronavirus-Erasmus Medical Center, which first appeared April 2012 in the Middle East, have discovered helpful details about its str more

  • Pain reliever shows anti-viral activity against flu

    The over-the-counter anti-inflammatory drug naproxen may also exhibit antiviral activity against influenza A virus, according to a team of French scientists. New influenza vaccines must be developed annually, because the surface proteins they target mutate rapidly, the way cars used to get a whole n more

  • Higher indoor humidity inactivates flu virus particles

    Higher humidity levels indoors can significantly reduce the infectivity of influenza virus particles released by coughing, according to research published in PLOS ONE by John Noti and colleagues from the National Institute for Occupational Safety and Health, Centers for Disease Control and Preventio more

All news on influenza

Publications Influenza

All publications on influenza

Market studies Influenza

  • BIOQUAL, Inc. - Strategic SWOT Analysis Review

    BIOQUAL, Inc. (Bioqual) is a public traded, research, development and consulting company and is engaged in providing quality research, development and consulting services to Government and commercial contract clients. The company is accredited by the association for the assessment and accreditation more

  • iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

    iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

  • Influenza – Pipeline Review, H1 2012

    Introduction Global Markets Direct’s, 'Influenza - Pipeline Review, H1 2012', provides an overview of the Influenza therapeutic pipeline. This report provides information on the therapeutic development for Influenza, complete with latest updates, and special features on late-stage and discontinued more

All market studies on influenza

Websites Influenza

Cytos Biotechnology - Preventing Chronic Diseases– a Vital Investment

News Events Overview Rationale for Immunodrugs™ Strategy Board & Management Industry Collaborations Letter of the CEO History Overview Immunodrug™ Platform Immunodrug™ Manufacturing Scientific Collaborations Scientific Publications Pipeline Clinical Trials Disease Areas Overview Board & Management S more

Gen-Probe, Gen Probe, GenProbe, GPRO, Nucleic Acid Test (NAT), (NATs), Blood Screening, Testing, Rap

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more

Isconova

Contact us About Isconova News & Press Home Applications ISCOM Technology Business collaborations Products About Adjuvants What is an Adjuvant? An adjuvant is essentially a substance that stimulates the immune response to an antigen without having any antigenic effects itself. The phrase “adjuvant” more

All websites on influenza
Related topics
Definition

Influenza

Influenza Influenza, commonly known as flu, is an infectious disease of bird s and mammal s caused by RNA virus es of the family Orthomyxoviridae (the influenza viruses). In humans, common symptoms of influenza are fever , sore throat , mu ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE